Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
Nash MA, Lenzi R, Edwards CL, Kavanagh JJ, Kudelka AP, Verschraegen CF, Platsoucas CD, Freedman RS. Nash MA, et al. Among authors: kavanagh jj. Clin Exp Immunol. 1998 May;112(2):172-80. doi: 10.1046/j.1365-2249.1998.00576.x. Clin Exp Immunol. 1998. PMID: 9649178 Free PMC article.
A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancer.
Kavanagh JJ, Edwards CL, Freedman RS, Finnegan MB, Balat O, Tresukosol D, Burk K, Loechner S, Hord M, Franklin JL, et al. Kavanagh JJ, et al. Gynecol Oncol. 1995 Jul;58(1):106-9. doi: 10.1006/gyno.1995.1191. Gynecol Oncol. 1995. PMID: 7789874 Clinical Trial.
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial.
Freedman RS, Edwards CL, Kavanagh JJ, Kudelka AP, Katz RL, Carrasco CH, Atkinson EN, Scott W, Tomasovic B, Templin S, et al. Freedman RS, et al. Among authors: kavanagh jj. J Immunother Emphasis Tumor Immunol. 1994 Oct;16(3):198-210. doi: 10.1097/00002371-199410000-00004. J Immunother Emphasis Tumor Immunol. 1994. PMID: 7834119 Clinical Trial.
374 results